Cargando…
Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians
BACKGROUND: Warfarin, the most commonly used antithrombotic agent for stroke prophylaxis in atrial fibrillation (AF), requires regular monitoring, frequent dosage adjustments, and dietary restrictions. Clinicians’ perceptions of barriers to optimal AF management are an important factor in treatment....
Autores principales: | Decker, Carole, Garavalia, Linda, Garavalia, Brian, Simon, Teresa, Loeb, Matthew, Spertus, John A, Daniel, William C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426274/ https://www.ncbi.nlm.nih.gov/pubmed/22936848 http://dx.doi.org/10.2147/JMDH.S33045 |
Ejemplares similares
-
Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers
por: Decker, Carole, et al.
Publicado: (2008) -
“I'm Not Just a Heart, I'm a Whole Person Here”: A Qualitative Study to Improve Sexual Outcomes in Women With Myocardial Infarction
por: Abramsohn, Emily M., et al.
Publicado: (2013) -
Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy
por: Yao, Catherine, et al.
Publicado: (2022) -
Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014) -
Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation
por: Rymer, Jennifer A., et al.
Publicado: (2021)